Page last updated: 2024-12-11
cinnamylamine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6008559 |
SCHEMBL ID | 1872 |
MeSH ID | M0163241 |
Synonyms (29)
Synonym |
---|
cinnamylamine |
3-phenylprop-2-en-1-amine |
RDAFNSMYPSHCBK-QPJJXVBHSA-N |
4360-51-4 |
(2e)-3-phenyl-2-propen-1-amine |
(e)-3-phenylprop-2-en-1-amine |
EN300-75742 |
4335-60-8 |
AKOS005175005 |
3-phenyl-2-propen-1-amine |
unii-7360f8ga70 |
2-propen-1-amine, 3-phenyl- |
7360f8ga70 , |
3-amino-1-phenylprop-1-ene |
cyclopropanamine, 2-phenyl-, hydrochloride, (1r,2r)-rel-2-propen-1-amine, 3-phenyl-, (2e)- |
(2e)-3-phenyl-2-propenylamine |
trans-cinnamylamine |
trans-3-phenyl-2-propenylamine |
kru5188qar , |
cinnamylamine, (e)- |
(e)-3-phenylallylamine |
(e)-cinnamylamine |
unii-kru5188qar |
SCHEMBL1872 |
AS-60263 |
(2e)-3-phenylprop-2-en-1-amine |
mfcd00062777 |
Q27282399 |
EN300-717557 |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.57
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.57) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |